|
|
Other links at Articles > Critical Care |
| 1. |
New MRSA Treatment Guidelines May Encourage Nephrotoxic Vancomycin Doses
|
|
|
Recent guidelines recommending vancomycin trough concentrations of 15-20 mg/L for patients with methicillin-resistant Staphylococcus aureus (MRSA) infections may prompt the use of vancomycin doses of 4 mg a day or greater -- doses that are associated with nephrotoxicity, investigators warn in the April issue of Antimicrobial Agents and Chemotherapy. Reuters Health Information
|
|
|